- Location
Eli Lilly
"-
Hutchison China Meditech Had Enrolled Patients for a Study of Colorectal Cancer
Sep 11, 2014Amid daily updates from the pharmaceuticals industry on the latest clinical trials, last week's announcement by Hutchison China MediTech that it had enrolled patients for a study of colorectal cancer was hardly cause for excitement. But ...
Tags: Health, Medicine, Chinese Pharma
-
Zymeworks Has Entered Into a Licensing and Collaboration Agreement with ImClone Systems
Jan 9, 2014Zymeworks Inc. today announced that it has entered into a licensing and collaboration agreement with ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, to develop an undisclosed number of novel bi-specific antibody ...
-
Suspended Drug Sales Focused Attention on a Feed Additive
Dec 27, 2013When the people from the drug company came out to visit Tyler Karney at Ordway Feedyard here on Colorado’s eastern plains, he was a little skeptical. They said their product, Zilmax, could put another 30 pounds on an animal in the ...
-
Most-recognized Anti-infective Brand in North America Is Cipro
Dec 23, 2013The most-recognized anti-infective brand in North America is Cipro. The brand was most-recognized by 7 percent of physicians in a survey conducted by Brand Institute Inc. during the second quarter of 2013. Cipro, comprising ciprofloxacin, ...
-
Ono Pharmaceuticals Has Elected to Amend and Expand The Existing Collaboration Agreement
Dec 12, 2013Receptos, a biopharmaceutical company, has announced that Ono Pharmaceuticals has elected to amend and expand the existing collaboration agreement between the parties to include transfer to Ono of the Receptos G-protein-coupled receptor ...
Tags: Pharmaceuticals, Receptos
-
Biozone Pharmaceuticals Has Agreed to Terms and Signed a Letter of Intent to Merge
Nov 29, 2013US-based Biozone Pharmaceuticals has announced that it has agreed to terms and signed a letter of intent (LOI) to merge with Cocrystal Discovery, a privately-held biotechnology company developing antiviral therapeutics for human diseases. ...
-
Eli Lilly and Company Has Received Priority Review Status From The FDA
Oct 25, 2013Eli Lilly and Company has received priority review status from the US Food and Drug Administration (FDA) for its ramucirumab (IMC-1121B) as a single-agent treatment for advanced gastric cancer following disease progression after initial ...
Tags: Cancer Drug, FDA Priority
-
Two Scientists From Eli Lilly and Company Are Accused
Oct 11, 2013Media reports said that two scientists from Eli Lilly and Company are accused for leaking business secrets worth USD 55 million to Jiangsu Hengrui Medicine Co., Ltd. (SHSE: 600276). The Chinese drug maker clarified that it has been abiding ...
Tags: Hengrui Medicine, Health, Medicine
-
Adimab Signed a Multi-Target Discovery Agreement with Celgene Corporation
Aug 22, 2013Adimab signed a multi-target discovery agreement with Celgene Corporation, pursuant to which, Adimab will use its proprietary discovery and optimization platform to generate fully human antibodies against multiple targets. Under the terms ...
Tags: Adimab, Drug Discovery
-
Adimab and Innovent to Discover, Develop and Commercialise an Antibody-Based Therapeutic
Aug 22, 2013Adimab and Innovent have collaborated to discover, develop and commercialise an antibody-based therapeutic, using Adimab antibody discovery and optimization platform, against a selected specific target. All initial product development ...
Tags: Adimab, Antibody-Based Therapeutic
-
Eli Lilly and Company Has Reported 31% Increase in Net Income to $1.21bn
Jul 26, 2013Eli Lilly and Company has reported 31% increase in net income to $1.21bn, or $1.11 per diluted share, for the second quarter ended on 30 July 2013, compared to $923.6m, or $0.83, for the same period last year. Increase in net income and ...
-
EMA Accepted Eli Lilly and Boehringer Ingelheim's MAA for a Glargine Product
Jul 10, 2013The European Medicines Agency (EMA) has accepted Eli Lilly and Company and Boehringer Ingelheim's marketing authorisation application (MAA) for a new insulin glargine product, LY2963016, for review. The application has been filed through ...
-
Specialized Diagnostic Kits Manufacturer Corgenix Has Development with Eli Lilly
May 23, 2013Specialized diagnostic kits manufacturer Corgenix has signed an agreement with Eli Lilly and Company, a US-based pharmaceutical company, to develop diagnostic technology in support of a Lilly oncology pipeline program. As per the ...
-
Types of Virus - on to Food to Attack and Kill Harmful Bacteria Is Becoming More Popular.
May 15, 2013The study in the Journal of the Science of Food and Agriculture states deploying bacteriophages –types of virus – directly on to food to attack and kill harmful bacteria is becoming more popular. Recent studies “strongly ...
-
Insulet Corporation and Eli Lilly Will Develop a New Version of The Omnipod Insulin Pump
May 6, 2013Insulet Corporation and Eli Lilly and Company have entered into a collaboration under which Insulet will develop a new version of the OmniPod insulin pump designed to deliver Humulin R U-500 insulin. R U-500 insulin is a regular U-500 ...
Tags: Insulet, Eli Lilly, Insulin Pump
